Sublingual Buprenorphine and Methadone Maintenance Treatment: A Three-Year Follow-Up of Quality of Life Assessment

This study was conducted to compare long-term outcome effects on the quality of life (QOL) of oral methadone with sublingual buprenorphine maintenance treatment. The QOL status of opioid-dependent patients was assessed using the German version (“Berlin Quality of Life Profile”) of the Lancashire Qua...

Full description

Saved in:
Bibliographic Details
Main Authors: Salvatore M. Giacomuzzi, Markus Ertl, Georg Kemmler, Yyvonne Riemer, Alexander Vigl
Format: Article
Language:English
Published: Wiley 2005-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1100/tsw.2005.52
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556667144765440
author Salvatore M. Giacomuzzi
Markus Ertl
Georg Kemmler
Yyvonne Riemer
Alexander Vigl
author_facet Salvatore M. Giacomuzzi
Markus Ertl
Georg Kemmler
Yyvonne Riemer
Alexander Vigl
author_sort Salvatore M. Giacomuzzi
collection DOAJ
description This study was conducted to compare long-term outcome effects on the quality of life (QOL) of oral methadone with sublingual buprenorphine maintenance treatment. The QOL status of opioid-dependent patients was assessed using the German version (“Berlin Quality of Life Profile”) of the Lancashire Quality of Life Profile. Physical symptoms were measured using the Opiate Withdrawal Scale (OWS). Urine tests were carried out randomly to detect additional consumption. In the first study period, 53 opioid-dependent subjects were enrolled and 25 could be reached after 3 years. The retention rate was 50% for methadone and 45% for buprenorphine (p = 0.786). Baseline values of the total sample (completers and noncompleters) QOL and somatic complaints did not show significant differences between the two treatment groups. QOL characteristics at 6 months of treatment of the buprenorphine completer and noncompleter groups differed significantly regarding job (p = 0.013), family, and total score of physical symptoms (p = 0.002), in which the completer group showed the more favorable values. Concerning physical symptoms at 36 months, logistic regression revealed significantly less stomach cramps (p = 0.037) and fatigue and tiredness (p = 0.034) in buprenorphine compared to the methadone. Moreover, the buprenorphine-maintained group showed significantly less additional consumption of benzodiazepines (p = 0.015) compared with methadone participants. It is concluded that opioid addicts improved their QOL and health status when treated with methadone or buprenorphine. In summary, regarding QOL and health status, the present data indicate that buprenorphine is also a useful long-term alternative for maintenance treatment of opioid-dependent patients.
format Article
id doaj-art-43bc331ea4aa405c96c6e7f104e9f48a
institution Kabale University
issn 1537-744X
language English
publishDate 2005-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-43bc331ea4aa405c96c6e7f104e9f48a2025-02-03T05:44:43ZengWileyThe Scientific World Journal1537-744X2005-01-01545246810.1100/tsw.2005.52Sublingual Buprenorphine and Methadone Maintenance Treatment: A Three-Year Follow-Up of Quality of Life AssessmentSalvatore M. Giacomuzzi0Markus Ertl1Georg Kemmler2Yyvonne Riemer3Alexander Vigl4University Department of Psychiatry, Anichstraße 35, 6020 Innsbruck, AustriaUniversity Department of Psychiatry, Anichstraße 35, 6020 Innsbruck, AustriaUniversity Department of Psychiatry, Anichstraße 35, 6020 Innsbruck, AustriaUniversity Department of Psychiatry, Anichstraße 35, 6020 Innsbruck, AustriaUniversity Department of Psychiatry, Anichstraße 35, 6020 Innsbruck, AustriaThis study was conducted to compare long-term outcome effects on the quality of life (QOL) of oral methadone with sublingual buprenorphine maintenance treatment. The QOL status of opioid-dependent patients was assessed using the German version (“Berlin Quality of Life Profile”) of the Lancashire Quality of Life Profile. Physical symptoms were measured using the Opiate Withdrawal Scale (OWS). Urine tests were carried out randomly to detect additional consumption. In the first study period, 53 opioid-dependent subjects were enrolled and 25 could be reached after 3 years. The retention rate was 50% for methadone and 45% for buprenorphine (p = 0.786). Baseline values of the total sample (completers and noncompleters) QOL and somatic complaints did not show significant differences between the two treatment groups. QOL characteristics at 6 months of treatment of the buprenorphine completer and noncompleter groups differed significantly regarding job (p = 0.013), family, and total score of physical symptoms (p = 0.002), in which the completer group showed the more favorable values. Concerning physical symptoms at 36 months, logistic regression revealed significantly less stomach cramps (p = 0.037) and fatigue and tiredness (p = 0.034) in buprenorphine compared to the methadone. Moreover, the buprenorphine-maintained group showed significantly less additional consumption of benzodiazepines (p = 0.015) compared with methadone participants. It is concluded that opioid addicts improved their QOL and health status when treated with methadone or buprenorphine. In summary, regarding QOL and health status, the present data indicate that buprenorphine is also a useful long-term alternative for maintenance treatment of opioid-dependent patients.http://dx.doi.org/10.1100/tsw.2005.52
spellingShingle Salvatore M. Giacomuzzi
Markus Ertl
Georg Kemmler
Yyvonne Riemer
Alexander Vigl
Sublingual Buprenorphine and Methadone Maintenance Treatment: A Three-Year Follow-Up of Quality of Life Assessment
The Scientific World Journal
title Sublingual Buprenorphine and Methadone Maintenance Treatment: A Three-Year Follow-Up of Quality of Life Assessment
title_full Sublingual Buprenorphine and Methadone Maintenance Treatment: A Three-Year Follow-Up of Quality of Life Assessment
title_fullStr Sublingual Buprenorphine and Methadone Maintenance Treatment: A Three-Year Follow-Up of Quality of Life Assessment
title_full_unstemmed Sublingual Buprenorphine and Methadone Maintenance Treatment: A Three-Year Follow-Up of Quality of Life Assessment
title_short Sublingual Buprenorphine and Methadone Maintenance Treatment: A Three-Year Follow-Up of Quality of Life Assessment
title_sort sublingual buprenorphine and methadone maintenance treatment a three year follow up of quality of life assessment
url http://dx.doi.org/10.1100/tsw.2005.52
work_keys_str_mv AT salvatoremgiacomuzzi sublingualbuprenorphineandmethadonemaintenancetreatmentathreeyearfollowupofqualityoflifeassessment
AT markusertl sublingualbuprenorphineandmethadonemaintenancetreatmentathreeyearfollowupofqualityoflifeassessment
AT georgkemmler sublingualbuprenorphineandmethadonemaintenancetreatmentathreeyearfollowupofqualityoflifeassessment
AT yyvonneriemer sublingualbuprenorphineandmethadonemaintenancetreatmentathreeyearfollowupofqualityoflifeassessment
AT alexandervigl sublingualbuprenorphineandmethadonemaintenancetreatmentathreeyearfollowupofqualityoflifeassessment